ATG5 selectively engages virus-tethered BST2/tetherin in an LC3C-associated pathway
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2217451120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Delphine Judith und 9 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Institut Cochin, INSERM, CNRS, F-75014 Paris, France. Hauptthemen laut MEDLINE: Bone Marrow Stromal Antigen 2, Viruses. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Sidaction.
Abstract (Originalsprache)
Bone marrow stromal antigen 2 (BST2)/tetherin is a restriction factor that reduces HIV-1 dissemination by tethering virus at the cell surface. BST2 also acts as a sensor of HIV-1 budding, establishing a cellular antiviral state. The HIV-1 Vpu protein antagonizes BST2 antiviral functions via multiple mechanisms, including the subversion of an LC3C-associated pathway, a key cell intrinsic antimicrobial mechanism. Here, we describe the first step of this viral-induced LC3C-associated process. This process is initiated at the plasma membrane through the recognition and internalization of virus-tethered BST2 by ATG5, an autophagy protein. ATG5 and BST2 assemble as a complex, independently of the viral protein Vpu and ahead of the recruitment of the ATG protein LC3C. The conjugation of ATG5 with ATG12 is dispensable for this interaction. ATG5 recognizes cysteine-linked homodimerized BST2 and specifically engages phosphorylated BST2 tethering viruses at the plasma membrane, in an LC3C-associated pathway. We also found that this LC3C-associated pathway is used by Vpu to attenuate the inflammatory responses mediated by virion retention. Overall, we highlight that by targeting BST2 tethering viruses, ATG5 acts as a signaling scaffold to trigger an LC3C-associated pathway induced by HIV-1 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, Institut Cochin, INSERM, CNRS, F-75014 Paris, France.
ORCID-Profile: Delphine Judith, Sarah Gallois-Montbrun, Katy Janvier, Clarisse Berlioz-Torrent
Förderung
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales
- Sidaction
Zitieren
APA
Judith, D., Versapuech, M., Bejjani, F., Palaric, M., Verlhac, P., Kuster, A., Lepont, L., Gallois-Montbrun, S., Janvier, K., & Berlioz-Torrent, C. (2023). ATG5 selectively engages virus-tethered BST2/tetherin in an LC3C-associated pathway. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2217451120
Vancouver
Judith D, Versapuech M, Bejjani F, Palaric M, Verlhac P, Kuster A, et al. ATG5 selectively engages virus-tethered BST2/tetherin in an LC3C-associated pathway. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2217451120
BibTeX
@article{Judith2023,
author = {Judith, Delphine and Versapuech, Margaux and Bejjani, Fabienne and Palaric, Marjory and Verlhac, Pauline and Kuster, Aurelia and Lepont, Leslie and Gallois-Montbrun, Sarah and Janvier, Katy and Berlioz-Torrent, Clarisse},
title = {ATG5 selectively engages virus-tethered BST2/tetherin in an LC3C-associated pathway},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2217451120}
}
EUVIMED